<DOC>
	<DOCNO>NCT02978898</DOCNO>
	<brief_summary>Background : Altered Toll-like receptor ( TLR ) expression level and/or mutation signal pathway ( MyD88 mutation ) contribute pathogenesis lymphoproliferative disorder ( LPD ) . CD180 orphan member TLR family modulate signal several TLRs , limited study evaluate expression flow cytometry ( FCM ) LPD . Methods : Using multiparameter FCM approach , biologist assess CD180 mean fluorescence intensity ( MFI ) lymph node ( LNs ) peripheral blood ( PB ) sample obtain patient follicular lymphoma ( FL ; LN/PB , n=44/n=15 ) , chronic lymphocytic leukemia ( CLL , n=26/n=21 ) , mantle cell lymphoma ( MCL , n=13/n=17 ) , marginal zone lymphoma ( MZL , n=16/n=12 ) . Specimens non-tumoral PB LN ( n=8/n=12 ) use control .</brief_summary>
	<brief_title>CD180 Overexpression Follicular Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<criteria>Samples patient : LF : Follicular lymphoma MCL : Mantle cell lymphoma CLL/SLL : chronic lymphocytic leukemia/small lymphocytic leukemia MZL : splenic marginal zone Clt : control Bcells Patient &lt; 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Follicular Lymphoma</keyword>
	<keyword>flow cytometry</keyword>
	<keyword>CD180</keyword>
	<keyword>Toll-like receptor</keyword>
	<keyword>lymphoproliferative disease</keyword>
</DOC>